Literature DB >> 17913649

Cognitive dysfunction in people with cancer.

Sanne B Schagen1, Janette Vardy.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17913649     DOI： 10.1016/S1470-2045(07)70287-5

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  13 in total

1.  [Impaired cognitive function and structural changes in cerebral white matter after chemotherapy].

Authors:  M Wilhelm
Journal:  Strahlenther Onkol       Date:  2012-06       Impact factor: 3.621

2.  Cognitive function after the initiation of adjuvant endocrine therapy in early-stage breast cancer: an observational cohort study.

Authors:  Patricia A Ganz; Laura Petersen; Steven A Castellon; Julienne E Bower; Daniel H S Silverman; Steven W Cole; Michael R Irwin; Thomas R Belin
Journal:  J Clin Oncol       Date:  2014-09-29       Impact factor: 44.544

3.  CogState computerized memory tests in patients with brain metastases: secondary endpoint results of NRG Oncology RTOG 0933.

Authors:  Chip Caine; Snehal Deshmukh; Vinai Gondi; Minesh Mehta; Wolfgang Tomé; Benjamin W Corn; Andrew Kanner; Howard Rowley; Vijayananda Kundapur; Albert DeNittis; Jeffrey Noah Greenspoon; Andre A Konski; Glenn S Bauman; Adam Raben; Wenyin Shi; Merideth Wendland; Lisa Kachnic
Journal:  J Neurooncol       Date:  2015-10-28       Impact factor: 4.130

Review 4.  Broadening the cancer and cognition landscape: the role of self-regulatory challenges.

Authors:  Jamie Arndt; Enny Das; Sanne B Schagen; Stephanie A Reid-Arndt; Linda D Cameron; Tim A Ahles
Journal:  Psychooncology       Date:  2013-07-10       Impact factor: 3.894

5.  Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging.

Authors:  Michiel B de Ruiter; Liesbeth Reneman; Willem Boogerd; Dick J Veltman; Matthan Caan; Gwenaëlle Douaud; Cristina Lavini; Sabine C Linn; Epie Boven; Frits S A M van Dam; Sanne B Schagen
Journal:  Hum Brain Mapp       Date:  2011-09-23       Impact factor: 5.038

6.  Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer.

Authors:  Michiel B de Ruiter; Liesbeth Reneman; Willem Boogerd; Dick J Veltman; Frits S A M van Dam; Aart J Nederveen; Epie Boven; Sanne B Schagen
Journal:  Hum Brain Mapp       Date:  2010-07-28       Impact factor: 5.038

7.  Cognitive effects of donepezil therapy in patients with brain tumors: a pilot study.

Authors:  Denise D Correa; Maria Kryza-Lacombe; Raymond E Baser; Kathryn Beal; Lisa M DeAngelis
Journal:  J Neurooncol       Date:  2016-01-06       Impact factor: 4.130

8.  Interventions to Alleviate Symptoms Related to Breast Cancer Treatments and Areas of Needed Research.

Authors:  Michelle C Janelsins; Karen M Mustian; Luke J Peppone; Lisa K Sprod; Michelle Shayne; Supriya Mohile; Kavita Chandwani; Jennifer S Gewandter; Gary R Morrow
Journal:  J Cancer Sci Ther       Date:  2011-09-29

9.  Preliminary exploration of a computerized cognitive battery and comparison with traditional testing in patients with high-grade glioma.

Authors:  Jane H Cerhan; Chip Caine; S Keith Anderson; Derek R Johnson; Daniel H Lachance; Elizabeth Yan; Paul D Brown
Journal:  Neurooncol Pract       Date:  2018-05-21

10.  International Cognition and Cancer Task Force Recommendations for Neuroimaging Methods in the Study of Cognitive Impairment in Non-CNS Cancer Patients.

Authors:  Sabine Deprez; Shelli R Kesler; Andrew J Saykin; Daniel H S Silverman; Michiel B de Ruiter; Brenna C McDonald
Journal:  J Natl Cancer Inst       Date:  2018-03-01       Impact factor: 13.506
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.